Home

HAROLD R WERNER

CIK 1013603 · last filed 2018-08-01

HAROLD R WERNER is a corporate insider who has filed 11 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for LPTX, was dated Aug 1, 2018. Across all open-market trades the lifetime net is +$1.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $13.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.20M

Companies

7

Total Filings

11

Lifetime Open-Market Net

$1.81M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted 10%+ Owner — $1.56 — $0 1 2018-08-01
GLOBEIMMUNE INC (GBIM) Delisted 10%+ Owner 564,267 — — -$319.9K 2 2016-02-19
XNCR Director 1,035,407 $12.74 $13.20M $0 1 2013-12-06
Altimmune, Inc. (PIP) Delisted 10%+ Owner — — — $0 1 2009-07-30
MiddleBrook Pharmaceuticals, Inc. (MBRK) Delisted Director — — — $0 2 2009-06-24
GENVEC INC (GNVC) Delisted Director — — — $0 1 2007-06-15
MiddleBrook Pharmaceuticals, Inc. (AVNC) Delisted Director 11,863,327 — — $2.13M 2 2007-05-23

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-08-01 CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted Other (J) — $0 EDGAR
2016-02-19 GLOBEIMMUNE INC (GBIM) Delisted Sell (S) −105,000 -$151.2K EDGAR
2016-02-16 GLOBEIMMUNE INC (GBIM) Delisted Sell (S) −105,000 -$168.7K EDGAR
2013-12-06 XNCR Conv (C) +1,035,407 $0 EDGAR
2011-12-23 — Buy (P) — $0
2009-07-30 Altimmune, Inc. (PIP) Delisted Mixed — $0 EDGAR
2009-06-24 MiddleBrook Pharmaceuticals, Inc. (MBRK) Delisted Grant (A) — $0 EDGAR
2008-06-19 MiddleBrook Pharmaceuticals, Inc. (MBRK) Delisted Grant (A) — $0 EDGAR
2007-06-15 GENVEC INC (GNVC) Delisted Grant (A) — $0 EDGAR
2007-05-23 MiddleBrook Pharmaceuticals, Inc. (AVNC) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.